Evelo: Evelo Bio Shutdown Follows a Series of Microbiome Therapy Trial Failures

Evelo Biosciences' vision of using microbes to engage the gut and modulate immune responses remains unrealized. With financing prospects dim and no one willing to take on its assets, Evelo is dissolving its business.